Form 8-K - Current report:
SEC Accession No. 0001213900-24-089338
Filing Date
2024-10-21
Accepted
2024-10-21 17:00:01
Documents
14
Period of Report
2024-10-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0218143-8k_onconetix.htm   iXBRL 8-K 34856
2 LETTER FROM EISNERAMPER LLP ea0218143-8kex16i_onconetix.htm EX-16.1 2393
  Complete submission text file 0001213900-24-089338.txt   213262

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE onco-20241015.xsd EX-101.SCH 3018
4 XBRL LABEL FILE onco-20241015_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE onco-20241015_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0218143-8k_onconetix_htm.xml XML 3687
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 241384003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)